GlaxoSmithKline (GSK) is a global pharmaceutical company with the majority of sales coming from pharmaceuticals followed by consumer healthcare. Most of the growth for GSK is coming from consumer healthcare because of declining pharmaceutical sales and margins from mature markets. The sector is highly dependent on expensive, long term R&D to develop new drugs. To establish a stronger brand presence in China and India, the company has aggressively cut prices to increase volumes in these markets.